When an expansive curlicue of tissue sitting below the ovaries was discovered more than a century ago, it was dismissed as useless and erased from biology textbooks. Biologists now are taking a new ...

Recent research sought to determine which patients with HR-positive breast cancer can benefit by adding ovarian function suppression to their adjuvant regimens, and which patients can skip it. A tumor ...

Known as "the silent killer" due to its lack of symptoms and reliable screening tests, ovarian cancer remains one of the ...

A new ovarian cancer surveillance test is now being offered to women with an inherited risk of the disease, marking a significant development in care. University College London Hospitals NHS ...

Ovarian function suppression (OFS) with gonadotropin-releasing hormone agonists (GnRHas) is a standard of care for premenopausal patients with high-risk stage II/III hormone receptor–positive breast ...

A new blood test could help diagnose cancer cases earlier. Researchers from the University of Southern California (USC) developed a blood test to detect early onset ovarian cancer. The test, called ...